Delivery Order SPE2DR25D1100-SPE2DR26FCS6E
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for CellCept 500 mg tablets (100-count units) with a ceiling value of $17,869.02 under a firm fixed-price contract type. The award was issued on December 8, 2025, with an ultimate completion date of December 9, 2025, and utilized no set-aside designation, indicating the award was competitively procured. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania—the specified place of performance—is a major...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $27,304.35 by the Defense Logistics Agency on July 10, 2025, for the supply of CellCept 500 mg tablets in quantities of 100. The contract, designated as a child agreement under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), carries an ultimate completion date of July 11, 2025. This award was competitively procured with no...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a competitively awarded delivery order (Contract No. 4568982464) by the Defense Logistics Agency on August 4, 2025, for the supply of CellCept 500 mg tablets in a quantity of 100 units. This firm fixed-price delivery order carries a ceiling value of $7,817.19 and is scheduled for ultimate completion by August 5, 2025. The contract carries no set-aside designation and will be...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order contract award from the Defense Logistics Agency's Medical Supply Chain for the supply of CellCept 500 mg tablets (500-count bottles). The contract, awarded May 12, 2025, carries a firm fixed price ceiling value of $8,316.17 with an ultimate completion date of May 13, 2025. This delivery order represents a non-set-aside, competitively awarded procurement and is classified as a child contract under...
- The Defense Logistics Agency awarded a $13,249.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of CellCept 500 mg tablets (500-count units). The contract was competitively awarded without set-aside designation and is set for completion by September 16, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under...
- The Defense Department's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on April 23, 2025, valued at $7,818.08 for 100 tablets of CellCept 500 mg, with final delivery due by April 24, 2025. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order placed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical. The vendor, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $33,203.38 to AmerisourceBergen Drug Corp for the supply of CellCept 500 mg tablets (500-count units). This competitive, firm fixed-price delivery order was executed on August 21, 2025, with an ultimate completion date of August 22, 2025. The contract does not carry a set-aside designation, indicating it was awarded through open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for CellCept 500 mg tablets (500-count packages) valued at $12,029.30 under a firm fixed-price contract type. This award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion pharmaceutical supply vehicle running through December 2026. CellCept (mycophenolate mofetil) is an...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on May 2, 2025, for the supply of CellCept 500 mg tablets (100-count units) with a ceiling value of $2,987.17. The contract is a firm fixed-price delivery order with an ultimate completion date of May 5, 2025 and was competitively awarded with no set-aside designation. The award is funded by the Medical Supply Chain, a defense-oriented federal agency, with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of CellCept 500 mg tablets (100 count) on September 8, 2025, with an ultimate completion date of September 9, 2025. This competitively awarded, firm fixed-price delivery order has a ceiling value of $27,735.62 and carries no set-aside designation. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters as a...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCS6EDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of CellCept 500 mg tablets (100-count units) valued at $40,333.39. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 4, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle that provides comprehensive pharmaceutical support to military healthcare programs worldwide through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor specializing in brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. The company's extensive portfolio of delivery orders with the Defense Logistics Agency demonstrates its capability to meet federal healthcare requirements through open competition, supporting military and veteran healthcare systems as well as other government healthcare entities including the Defense Health Agency and U.S. Coast Guard. No set-aside designation was applied to this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $40.3k | 12/2/25 |